Peapack Gladstone Financial Corp Atea Pharmaceuticals, Inc. Transaction History

Peapack Gladstone Financial Corp

  • $6.51 Billion
  • Q2 2024

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 14, 2023
SELL
$3.0 - $3.79 $2,250 - $2,842
-750 Reduced 4.49%
15,946 $48,000
Q4 2022

Feb 14, 2023
SELL
$4.35 - $6.17 $43,500 - $61,700
-10,000 Reduced 37.46%
16,696 $80,000
Q2 2022

Aug 12, 2022
SELL
$5.33 - $8.18 $3,731 - $5,726
-700 Reduced 2.56%
26,696 $190,000
Q4 2021

Feb 15, 2022
BUY
$7.67 - $44.59 $158,769 - $923,013
20,700 Added 309.14%
27,396 $245,000
Q3 2021

Nov 15, 2021
BUY
$21.33 - $35.06 $142,825 - $234,761
6,696 New
6,696 $235,000

Others Institutions Holding AVIR

# of Institutions
112
Shares Held
52.4M
Call Options Held
900
Put Options Held
126K
View Full List

About Atea Pharmaceuticals, Inc.

AVIR Quotes by TradingView
  • Ticker AVIR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 83,258,600
  • Market Cap $281M
  • Description
  • Atea Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focused on discovering, developing, and commercializing antiviral therapeutics for patients suffering from viral infections. Its lead product candidate is AT-527, an antiviral drug candidate that is in Phase II clinical trial for the treatment of patients with COVID-19. The ...
More about AVIR
Track This Portfolio

Track Peapack Gladstone Financial Corp Portfolio

Follow Peapack Gladstone Financial Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Peapack Gladstone Financial Corp, based on Form 13F filings with the SEC.

News

Stay updated on Peapack Gladstone Financial Corp with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email